Creyos (formerly Cambridge Brain Sciences)
Marc J. Lipton has extensive experience in executive leadership and private equity. Marc J. served as the President and CEO of Creyos (formerly Cambridge Brain Sciences) since 2015. Prior to that, they worked as a Partner at Torquest Partners from 2004 to 2015.
Marc J. Lipton completed their education at two prestigious institutions. Marc J. obtained a Master of Business Administration (M.B.A.) degree from the University of Toronto - Rotman School of Management, where they studied from 1990 to 1992. Prior to that, they earned a Bachelor of Applied Science (B.A.Sc.) degree from the Faculty of Applied Sciences and Engineering at the University of Toronto between 1986 and 1990.
Additionally, Marc J. Lipton holds the certification of CPA/CA from the Chartered Professional Accountants of Ontario (The Institute of Chartered Accountants of Ontario), though the specific month and year of obtaining this certification are not provided.
This person is not in any offices
Creyos (formerly Cambridge Brain Sciences)
1 followers
Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health. It allows you to obtain accurate, quantified and scientifically-validated measures of key aspects of cognition, including short-term memory, attention, reasoning, and verbal ability. Creyos offers two core products – Creyos Health and Creyos Research. Built for health care practitioners, Creyos Health is an online brain health assessment service that takes seconds to set up, is engaging and enjoyable for patients, and produces a reliable and scientifically-validated cognitive assessment report in as little as 15 minutes. It is used by leading health care clinics around the world to track brain health over time as part of cognitive treatment and wellness plans. Healthcare providers using Creyos Health also have access to digital versions of many standardized patient health questionnaires. Creyos Research is made for researchers running studies on cognition in academic and commercial settings, allowing for the collection of cognitive data at scale. It has been used by many leading institutions, including Baycrest, Pfizer and Roche. Both products allow for assessment customization and online administration, require no expert technical support to administer and enable you to store and manage cognitive data securely in the cloud. Creyos maintains a global normative database of more than 85,000 participants (built off of our larger database of 12+ million completed cognitive tasks) that enables you to derive detailed comparisons of individuals to specific populations. The Cambridge Brain Sciences (now Creyos) cognitive tasks were developed in the laboratory of Dr. Adrian Owen, Canada Excellence Research Chair in Cognitive Neuroscience and Imaging (owenlab.org), over the course of his 25-year career. Over 300 scientific studies have been run to date using our tests, yielding numerous publications in leading academic journals.
Employees
51-200